A

Accuray

Robotics-assisted, image-guided radiotherapy for cancer

EHS Specialist

Full-TimeUpdated on 10/23/2026
No salary listed
Senior
Bachelor's
Madison, WI, USA
In PersonTravel up to 5% of the time.
Facilities OperationsEnvironmental Health & Safety
No H1B Sponsorship

About the job

Requirements
  • A bachelor's degree in Environmental Health & Safety, Natural Science, Engineering, or a related field, or equivalent years of experience in lieu of a degree.
  • At least five years of experience working in an environmental, health, and safety capacity.
  • Current knowledge of federal, state, and local health and safety regulations, such as Occupational Safety and Health Administration regulations.
  • Familiarity with radiation safety requirements.
  • Strong written and verbal communication skills and the ability to influence, drive change, and build partnerships across all levels of the organization without direct authority.
  • Ability to manage multiple priorities, adapt to changing business needs, and work in a fast-paced, dynamic, and culturally diverse environment.
  • Self-motivated and highly organized, with strong administrative, documentation, and project management skills; able to work independently and collaborate effectively with cross-functional teams.
  • Attention to detail, sound judgment, and the ability to balance competing demands while delivering high-quality results.
  • Ability to lift up to 25 pounds and frequently walk, climb ladders, kneel, crouch, and crawl during job duties.
  • Ability to travel up to 5% of the time.
  • Must furnish proof of permanent authorization to work in the country of application without sponsorship.
Responsibilities
  • Develop, implement, maintain, and continuously improve environmental, health, and safety programs, policies, procedures, and work instructions to ensure regulatory compliance and effective risk management.
  • Monitor EHS program effectiveness and recommend improvements based on regulatory changes, audit findings, incident investigations, and operational needs.
  • Promote a positive safety culture by engaging employees and leaders in EHS initiatives, encouraging participation, and reinforcing accountability for safe work practices.
  • Partner with site leadership to establish safety objectives and support achievement of EHS performance goals.
  • Conduct workplace inspections, safety audits, risk assessments, and Job Hazard Analyses to identify hazards and opportunities for risk reduction.
  • Develop, track, and verify completion of corrective and preventive actions resulting from inspections, audits, incident investigations, and regulatory findings.
  • Develop, coordinate, and deliver EHS training programs for employees, contractors, and visitors on applicable safety requirements and safe work practices.
  • Maintain training records and monitor compliance with required training and certifications.
  • Investigate workplace incidents, injuries, near misses, and hazardous conditions; determine root causes and implement corrective actions to prevent recurrence.
  • Provide technical EHS guidance to employees, leaders, contractors, and consultants, and support regulatory inspections and audits.
  • Maintain awareness of applicable federal, state, and local EHS regulations and ensure site compliance.
  • Analyze EHS performance metrics, incident trends, training compliance, and audit findings to identify improvement opportunities and report progress to management.
  • Coordinate occupational health programs, medical surveillance requirements, and health-related compliance activities with external providers.
  • Maintain emergency response plans and participate in emergency preparedness activities, drills, and response team functions.
  • Partner with Global EHS leadership and external consultants to support radiation safety programs, training, audits, and regulatory compliance activities.
  • Manage personal protective equipment and safety supply programs to ensure availability, proper selection, and effective use.
  • Exercise stop-work authority when unsafe conditions or activities present a risk to personnel, property, or the environment.
Desired Qualifications
  • OSHA certification is preferred.

About the company

Accuray provides cancer-care technology that uses robotics and image guidance to deliver precise, non-invasive radiation treatments. Its flagship CyberKnife system places a robotic arm around the patient to aim highly focused radiation beams at tumors anywhere in the body, performing radiosurgery without surgery. In 2011 it expanded its product line by acquiring TomoTherapy, adding a helical radiation therapy platform to its portfolio, broadening the ways clinicians can treat cancer. The company differentiates itself by combining robotics with real-time imaging to track tumors and adjust treatment in real time, and by offering a broader, multi-product radiation oncology system rather than a single device. Accuray’s goal is to provide effective, non-invasive cancer treatments to patients worldwide, growing its global installed base and advancing access to precise radiation therapy.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Madison, Wisconsin

Founded

1990

Get referred to Accuray

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Fiscal 2026 transformation delivered over $20 million in cost and margin improvements.
  • Q4 fiscal 2026 service revenue rose 6%, supporting margins despite product weakness.
  • September 2026 Samsung NeuroLogica collaboration expands CyberKnife imaging ambitions before commercial launch.

What critics are saying

  • Fiscal 2026 revenue fell 12% to $401.9 million; product revenue dropped 27%.
  • Accuray withdrew fiscal 2026 guidance in May 2026 after Middle East shipment delays.
  • TCW's covenant holiday ends December 2027; another sales slump risks lender-controlled restructuring.

What makes Accuray unique

  • CyberKnife delivers robotic radiosurgery with sub-millimeter precision across body tumors since 2001.
  • Fiscal 2026 services supplied 57% of revenue, creating recurring installed-base economics.
  • UW-Madison's 10-year collaboration and Samsung NeuroLogica partnerships deepen Accuray's technology ecosystem.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Remote Work Options

Growth & Insights and Company News

6 month growth

0%

1 year growth

3%

2 year growth

3%
Third News
Oct 6th, 2026
Accuray stockholders approve $60M financing deal and board expansion

Accuray Incorporated announced stockholders approved all proposals at its 6 October 2026 special meeting, advancing a strategic financing agreement with TCW Asset Management Company LLC, its primary lender and major shareholder. The July 2026 deal converts $40 million of term loan debt into convertible preferred stock and includes a $15 million equity investment from TCW. Accuray also gains access to a delayed draw term loan of up to $5 million and relief from certain financial covenants until 31 December 2027. Approved measures include issuing common stock under Nasdaq rules, increasing authorised shares, and implementing a reverse stock split with a ratio between 1-for-15 and 1-for-40. The company also announced governance enhancements and board expansion.

Market Chameleon
Sep 28th, 2026
Accuray (ARAY) highlights Samsung NeuroLogica volumetric imaging collaboration for CyberKnife as shares jump during market hours.

Accuray (ARAY) highlights Samsung NeuroLogica volumetric imaging collaboration for CyberKnife as shares jump during market hours. 28 September 2026, 9:55 AM The collaboration aims to bring more volumetric imaging information into the treatment room, but no product has been announced. Accuray Incorporated (NASDAQ:ARAY) said it has entered into agreements with Samsung HME America, Inc., dba NeuroLogica Corp. ("Samsung NeuroLogica") to pursue advanced volumetric imaging capabilities for the CyberKnife System. The announcement coincided with the American Society of Radiation Oncology (ASTRO) Annual Meeting in Boston, where the companies are highlighting their collaboration. Accuray framed the effort as part of a broader strategy of targeted partnerships - pairing Samsung NeuroLogica's experience in mobile CT and volumetric imaging with Accuray's strengths in precision treatment delivery, robotic radiosurgery, and motion management. Importantly for investors, the company said the work will proceed through phased development and evaluation and that no commercial product offering has been announced.

Business Insider
Sep 27th, 2026
Accuray, Samsung NeuroLogica advance volumetric imaging collaboration.

Accuray, Samsung NeuroLogica advance volumetric imaging collaboration. Sep. 27, 2026, 11:25 AM Accuray Incorporated (ARAY) announced that it had entered into agreements with Samsung HME America (SSNLF) to pursue advanced volumetric imaging capabilities for the CyberKnife System. The announcement coincides with the American Society of Radiation Oncology, ASTRO, Annual Meeting in Boston, Massachusetts, where the companies are highlighting their collaboration. The collaboration represents another example of Accuray's strategy to address customer priorities through targeted partnerships that bring together complementary expertise. Published first on TheFly - the ultimate source for real-time, market-moving breaking financial news. Try Now>> Read More on ARAY:

Yahoo Finance
Aug 20th, 2026
Accuray secures $55M financing, cuts costs by $20M amid China headwinds and tariff uncertainty

Accuray Incorporated reported fiscal 2026 results, describing the year as foundational for streamlining operations and reducing costs. Geopolitical tensions and tariff uncertainty in China contributed to approximately $58 million in product revenue decline. The company achieved $20 million in cost and margin improvements, exceeding its initial $12 million target. Service revenue grew 6% in Q4, driven by strategic pricing and an expanding installed base. Accuray is pivoting to a partner-centric model, using nonbinding letters of intent with Samsung Medison and Research Laboratories to accelerate innovation. The company completed a restructuring transaction with TCW Asset Management, converting $40 million of debt into preferred equity. Management is not providing fiscal 2027 guidance due to geopolitical uncertainty. The company expects approximately $15 million in additional annualised cost improvements and has secured a covenant holiday through December 2027.

Yahoo Finance
Aug 20th, 2026
Accuray posts $402M revenue, achieves $20M cost savings amid 12% annual decline

Accuray reported Q4 2026 net revenue of $100.9 million, down 21% year-over-year, with full-year revenue at $402 million, down 12%. Product revenue fell 42% in Q4 to $40.8 million, whilst service revenue rose 6% to $60.1 million. The medical device company exceeded its transformation cost-saving target, achieving over $20 million in savings versus a $12 million goal. Q4 gross margin improved to 34.8% from 30.6% in the prior year. Accuray strengthened its balance sheet through a transaction with TCW, including debt conversion and a $15 million cash investment. The company ended Q4 with $48.8 million in cash and $313 million in order backlog. Full-year adjusted EBITDA was $10.6 million, down from $28.3 million in the prior year.